Serum Zinc Deficiency and Survival in Patients with Advanced Pancreatic and Biliary Tract Cancer

Background/Objectives: Evidence on the prognostic significance of serum zinc in advanced pancreatic cancer (APC) and biliary tract cancer (BTC) is limited. We assessed the prognostic significance of serum zinc deficiency at baseline and 3 months in APC and BTC. Methods: This post hoc analysis of a prospective observational cohort included 134 patients with APC and 41 with BTC. Zinc deficiency was defined as serum zinc < 60 μg/dL. Overall survival (OS) was evaluated from baseline and from a fixed 3-month landmark using Kaplan–Meier and Cox regression analyses. Results: Baseline zinc deficiency was present in 13/134 (10%) patients with APC and 9/41 (22%) with BTC and was not significantly associated with OS in either cohort. At 3 months, zinc deficiency was present in 25/90 (28%) patients with APC and 15/33 (45%) with BTC and was associated with shorter subsequent OS (APC: 5.2 vs. 13.8 months, p < 0.001; BTC: 3.7 vs. 14.9 months, p = 0.006). Among patients with normal baseline zinc, new deficiency at 3 months was associated with shorter subsequent OS in both cohorts. In APC, zinc deficiency remained associated with OS after adjustment for performance status, tumor location, disease control, hypoalbuminemia, and C-reactive protein (HR, 1.93; 95% CI, 1.12–3.32). The coexistence of zinc deficiency and hypoalbuminemia was associated with poorer survival than the presence of neither abnormality (adjusted HR, 2.59; 95% CI, 1.22–5.52). Conclusions: Zinc deficiency, defined by the clinical threshold of <60 μg/dL at the 3-month landmark but not at baseline, was associated with shorter subsequent survival in APC and BTC. Assessment of serum zinc during treatment may contribute to prognostic evaluation.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-18
DOI
https://doi.org/10.3390/jcm15229042
Primary Topic
Trace Elements in Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum Zinc Deficiency and Survival in Patients with Advanced Pancreatic and Biliary Tract Cancer

Masayuki Hijioka, Lingaku Lee, Masami Miki, Rie Sugimoto et al.
3 links
Journal of Clinical Medicine
Trace Elements in Health
article

Serum Zinc Deficiency and Survival in Patients with Advanced Pancreatic and Biliary Tract Cancer

Masayuki Hijioka, Lingaku Lee, Masami Miki, Rie Sugimoto, Terumasa Hisano, Yusuke Niina, Takeshi Senju, Yusuke Morita, Masayuki Furukawa, Miho Kurokawa, Yuki Tanaka
article en

Abstract

Background/Objectives: Evidence on the prognostic significance of serum zinc in advanced pancreatic cancer (APC) and biliary tract cancer (BTC) is limited. We assessed the prognostic significance of serum zinc deficiency at baseline and 3 months in APC and BTC. Methods: This post hoc analysis of a prospective observational cohort included 134 patients with APC and 41 with BTC. Zinc deficiency was defined as serum zinc < 60 μg/dL. Overall survival (OS) was evaluated from baseline and from a fixed 3-month landmark using Kaplan–Meier and Cox regression analyses. Results: Baseline zinc deficiency was present in 13/134 (10%) patients with APC and 9/41 (22%) with BTC and was not significantly associated with OS in either cohort. At 3 months, zinc deficiency was present in 25/90 (28%) patients with APC and 15/33 (45%) with BTC and was associated with shorter subsequent OS (APC: 5.2 vs. 13.8 months, p < 0.001; BTC: 3.7 vs. 14.9 months, p = 0.006). Among patients with normal baseline zinc, new deficiency at 3 months was associated with shorter subsequent OS in both cohorts. In APC, zinc deficiency remained associated with OS after adjustment for performance status, tumor location, disease control, hypoalbuminemia, and C-reactive protein (HR, 1.93; 95% CI, 1.12–3.32). The coexistence of zinc deficiency and hypoalbuminemia was associated with poorer survival than the presence of neither abnormality (adjusted HR, 2.59; 95% CI, 1.22–5.52). Conclusions: Zinc deficiency, defined by the clinical threshold of <60 μg/dL at the 3-month landmark but not at baseline, was associated with shorter subsequent survival in APC and BTC. Assessment of serum zinc during treatment may contribute to prognostic evaluation.

Journal of Clinical MedicineVol. 15(22)
National Hospital Organization Kyushu Cancer Center (JP)
Good health and well-being
Trace Elements in Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon